Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.

Slides:



Advertisements
Similar presentations
Physician Relationships with The Pharmaceutical Industry Steven R. Craig, MD, FACP June 22, 2010.
Advertisements

Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
1 The OII is here to help you! or An Introduction to Partners Policies on Interactions with Industry Office for Interactions.
The Physician-Pharmaceutical Industry Relationship.
Responsible Conduct in Research Conflict of Interest and Commitment.
Promoting Integrity in the Next Generation of Researchers A Curriculum for Responsible Conduct of Research in Occupational Therapy (2005) Funded by the.
Conflict of Interest/Conflict of Commitment NCURA Region VI & VII Spring Meeting Chandler, AZ April 2005.
Conflict of Interest in Physician-Industry Relationships
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
Financial Conflict of Interest and Medical Research
National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014 APGO Interaction with Industry: A Medical.
Personal financial benefit or economic interest from one’s position that may inappropriately: influence the employee’s judgment compromise the employee’s.
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
3 rd Party Entity A. Individual Financial Interests B. Spouse Financial Interests C. Dep. Children Financial Interests D. Collective (A+B+C) E. Significant.
FREDERIC W. HAFFERTY PH.D. PROFESSOR UNIVERSITY OF MINNESOTA SCHOOL OF MEDICINE–DULUTH Professionalism, Best Evidence & Medical Education: A Cautionary.
Conflicts of Interest James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Conflict of Interest and Technology Transfer Sherrie Settle Assistant Director, Research Compliance Program Institutional Conflict of Interest Officer.
Conflict of Interest in Medical Research, Education, and Practice Presentation for Secretary’s Advisory Committee on Human Research Protections July 22,
Fall 2014 Kate Walker, Vice President for Finance and Treasurer
Adapted from PRSSA and PRSA (Some of these are directly from PRSA, some of these I summed up) Ethics.
PROFESSIONALISM EDUCATION: POSSIBLE COMPETENCIES Barbara Barzansky, PhD, MHPE LCME Co-Secretary APHC Conference May 3, 2013.
Elissa Ladd, PhD, RN, FNP-BC ; Diane Mahoney, PhD, RN, GNP ; Sri Emani, PhD “UNDER THE RADAR”: NURSE PRESCRIBERS AND PHARMACEUTICAL INDUSTRY PROMOTIONS.
“opinion or feeling that strongly favours one side in an argument or one item in a group or series”
Conflict of Interest Curriculum Eric Jackson, PharmD University of Connecticut School of Medicine Department of Family Medicine.
Conflict of Interest Michelle Stickler, DEd Office for Research Protections
Teaching Professionalism to Residents: The Management of Conflict of Interest in Medicine NORMAN B. KAHN, JR. MD COUNCIL OF MEDICAL SPECIALTY SOCIETIES.
Tech Launch Arizona Tech Transfer Arizona Rakhi Gibbons, Asst. Director for Biomedical and Life Sciences Licensing.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Office of Regulatory Affairs  Institutional Conflict of Interest - Clinical Trials Committee (ICOI-CT)  Reviews research conflicts that arise…
North Shore – LIJ Health System PREP Workshop #4: How to Report and Manage External Interests (COIs) Electronically.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
May 1, 2003 University Town Hall Budget Meeting. 2 Considerations for Budget Planning Projected budget based on: –15% tuition increase –Enrollment held.
Will Disclosure Quiet the Industry’s Critics? Peter Lurie, MD, MPH Deputy Director Health Research Group at Public Citizen Presented before The National.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Doctors’ Ties to Drug Makers Are Put On Close View.
Transparency in Grants and Gifts Pfizer Approach Cathryn Clary, MD VP, US External Medical Affairs.
+ Conflict of Interest in Physician-Industry Relationships.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
Presenter name:Noel Juban, M.D, MsC Affiliation: Department of Clinical Epidemiology U.P. College of Medicine November 2011MeTA Process and Lessons from.
Are There Limits to Patient Autonomy? Elizabeth Heitman, PhD Vanderbilt University Medical Center Center for Biomedical Ethics and Society Challenges in.
+ Role of Industry in Clinical Care, Research, and Education.
Managing Conflicts of Interest at the IRB and Institutional Level: INSTITUTIONAL CONFLICTS OF INTEREST Claudia R. Adkison, J.D., Ph.D. Executive Associate.
Acknowledgements and Conflicts of interest Dr Gurpreet Kaur Associate Professor Dept of Pharmacology Government Medical College Amritsar.
An Educational Session on HSC OP 10.27, Health Care Vendor Interactions April 20, 2009.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Stanford Policy – Faculty ◦ Mission: Promote public good by transferring knowledge  Consulting  Technologies arising from research These activities can.
Japan Endovascular Treatment Conference 2015 JET2015 General Presentation.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Amir Qaseem, MD, PhD, MHA, FACP American College of Physicians May 11, 2011.
Portfolio Committee for Health Medicines and Related Substances Amendment Bill (06/08/08) IMSA represents Research Based Pharmaceutical Companies.
Industry Collaboration & Interactions With Health Professionals -- Can Conflicts of Interest be Properly Managed? Tom Stossel Brigham & Women’s Hospital.
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
Japan Endovascular Treatment Conference 2016 JET2016 General Presentation.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
Conflicts of Interest and Transparency Issues Susan Cantrell Vice President, Resources Development.
PUBLICATION PRINCIPLES for PUBLICATION PROFESSIONALS
EUROSAI Task Force on Audit & Ethics
“Conflicts of Interest”
Ethical Issues in Medical Writing
Cultural Communication Differences
What Should a Mission Do?
Presentation transcript:

Conflict of Interest

Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise or bias professional judgment and objectivity.” From Columbia University’s Conflict of Interest Policy

A Simpler Definition “Trying to Serve Two Masters” Lauris C. Kaldjian, MD, PhD Director, Program in Biomedical Ethics

A Bit of Background

Perceived Influence of Sales Reps on Prescribing Practices “You” “Other Physicians” Of Principles and Pens: Attitudes and practices of medicine house staff toward pharmaceutical promotions Am J Med 2001;110:551

Statements on Conflicts of Interest from: IOM / AAMC / ABIM  Commonly held belief that small gifts don’t influence behavior is disproved by social science research  C.O.I. is a rampant problem  Disclosure of financial interests is also a myth that incompletely protects patients  Academic Medical Centers must lead the way to abolish gifting practices JAMA 2006; 295:

S.2029 A bill from Senator Grassley  “...amend Social Security Act to provide transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies…”

And increasingly … We must also address patient/public perceptions that our activities may convey a potential for conflict of interest

Education Domains  UME  GME  CME Dealing with drug sampling, free meals, etc. Biopharma support for CME

Clinical Practice Drug sampling in Clinics Purchase decision making for medical devices Device consulting – for development & usage

Research  Basic  Clinical  Translational  Entrepreneurial Completeness of disclosure; is disclosure adequate? Intellectual property control & patents

Conflict of Interest Task Force Membership  (N=34)  Broad representation across the College and University Planned Approach  Inventory & Review Existing Policies (local & national)  Make recommendations with a comprehensive policy (across all 3 core missions) Timeline  roughly over 1 year

Comments? Suggestions? Questions?